AAAAAA
Results:
1-10
|
Results: 10
Authors:
Carbone, PP
Pirsch, JD
Thomas, JP
Douglas, JA
Verma, AK
Larson, PO
Snow, S
Tutsch, KD
Pauk, D
Citation: Pp. Carbone et al., Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants, CANC EPID B, 10(6), 2001, pp. 657-661
Authors:
Ramanathan, RK
Cnaan, A
Hahn, RG
Carbone, PP
Haller, DG
Citation: Rk. Ramanathan et al., Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282, ANN ONCOL, 12(8), 2001, pp. 1139-1143
Authors:
Carbone, PP
Citation: Pp. Carbone, Systemic therapy for older women with breast cancer - The Kimmick/Muss article reviewed, ONCOLOGY-NY, 15(3), 2001, pp. 291
Authors:
Balducci, L
Carbone, PP
Citation: L. Balducci et Pp. Carbone, Cancer in the elderly: Tailoring treatment, HOSP PRACT, 35(3), 2000, pp. 73-80
Authors:
Carbone, PP
Douglas, JA
Thomas, J
Tutsch, K
Pomplun, M
Hamielec, M
Pauk, D
Citation: Pp. Carbone et al., Bioavailability study of oral liquid and tablet forms of alpha-difluoromethylornithine, CLIN CANC R, 6(10), 2000, pp. 3850-3854
Authors:
Carbone, PP
Citation: Pp. Carbone, Advances in the systemic treatment of cancers in the elderly, CR R ONC H, 35(3), 2000, pp. 201-218
Authors:
Carbone, PP
Citation: Pp. Carbone, Oncology update for the millennium, ONCOL-BASEL, 58(1), 2000, pp. 1-2
Authors:
Hong, WK
Carbone, PP
Citation: Wk. Hong et Pp. Carbone, Cancer chemoprevention: Present status, future expectations, HOSP PRACT, 34(11), 1999, pp. 101-106
Authors:
Carbone, PP
Citation: Pp. Carbone, Cancer chemoprevention: Present status, future expectations - Commentary, HOSP PRACT, 34(11), 1999, pp. 105-106
Authors:
Witte, RS
Ryan, LM
Schutt, AJ
Carbone, PP
Engstrom, PF
Citation: Rs. Witte et al., PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma, INV NEW DR, 16(4), 1998, pp. 315-318
Risultati:
1-10
|